Top

Published in:

Open Access 01-12-2023 | Alzheimer's Disease | Research

ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease

Authors: Christopher E. Ramsden, Daisy Zamora, Mark S. Horowitz, Jahandar Jahanipour, Elizabeth Calzada, Xiufeng Li, Gregory S. Keyes, Helen C. Murray, Maurice A. Curtis, Richard M. Faull, Andrea Sedlock, Dragan Maric

Published in: Acta Neuropathologica Communications | Issue 1/2023

Abstract

In sporadic Alzheimer’s disease (sAD) specific regions, layers and neurons accumulate hyperphosphorylated Tau (pTau) and degenerate early while others remain unaffected even in advanced disease. ApoER2-Dab1 signaling suppresses Tau phosphorylation as part of a four-arm pathway that regulates lipoprotein internalization and the integrity of actin, microtubules, and synapses; however, the role of this pathway in sAD pathogenesis is not fully understood. We previously showed that multiple ApoER2-Dab1 pathway components including ApoE, Reelin, ApoER2, Dab1, pP85α_Tyr607, pLIMK1_Thr508, pTau_{Ser202/Thr205} and pPSD95_Thr19 accumulate together within entorhinal-hippocampal terminal zones in sAD, and proposed a unifying hypothesis wherein disruption of this pathway underlies multiple aspects of sAD pathogenesis. However, it is not yet known whether ApoER2-Dab1 disruption can help explain the origin(s) and early progression of pTau pathology in sAD. In the present study, we applied in situ hybridization and immunohistochemistry (IHC) to characterize ApoER2 expression and accumulation of ApoER2-Dab1 pathway components in five regions known to develop early pTau pathology in 64 rapidly autopsied cases spanning the clinicopathological spectrum of sAD. We found that (1) these selectively vulnerable neuron populations strongly express ApoER2; and (2) multiple ApoER2-Dab1 components representing all four arms of this pathway accumulate in abnormal neurons and neuritic plaques in mild cognitive impairment (MCI) and sAD cases and correlate with histological progression and cognitive deficits. Multiplex-IHC revealed that Dab1, pP85α_Tyr607, pLIMK1_Thr508, pTau_{Ser202/Thr205} and pPSD95_Thr19 accumulate together within many of the same ApoER2-expressing neurons and in the immediate vicinity of ApoE/ApoJ-enriched extracellular plaques. Collective findings reveal that pTau is only one of many ApoER2-Dab1 pathway components that accumulate in multiple neuroanatomical sites in the earliest stages of sAD and provide support for the concept that ApoER2-Dab1 disruption drives pTau-associated neurodegeneration in human sAD.

Available only for authorised users

Agster KL, Mejias-Aponte CA, Clark BD, Waterhouse BD (2013) Evidence for a regional specificity in the density and distribution of noradrenergic varicosities in rat cortex. J Comp Neurol 521:2195–2207. https://doi.org/10.1002/cne.23270CrossRefPubMedPubMedCentral

Anderson ML (2008) Multiple inference and gender differences in the effects of early intervention: a reevaluation of the abecedarian, Perry preschool, and early training projects. J Am Stat Assoc 103:1481–1495. https://doi.org/10.1198/016214508000000841CrossRef

Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42:631–639. https://doi.org/10.1212/wnl.42.3.631CrossRefPubMed

Aston-Jones G, Waterhouse B (2016) Locus coeruleus: from global projection system to adaptive regulation of behavior. Brain Res 1645:75–78. https://doi.org/10.1016/j.brainres.2016.03.001CrossRefPubMedPubMedCentral

Ayers JI, Giasson BI, Borchelt DR (2018) Prion-like spreading in tauopathies. Biol Psychiatry 83:337–346. https://doi.org/10.1016/j.biopsych.2017.04.003CrossRefPubMed

Baloyannis SJ (2005) Morphological and morphometric alterations of Cajal–Retzius cells in early cases of Alzheimer’s disease: a Golgi and electron microscope study. Int J Neurosci 115:965–980. https://doi.org/10.1080/00207450590901396CrossRefPubMed

Bass BP, Engel KB, Greytak SR, Moore HM (2014) A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: How well do you know your FFPE specimen? Arch Pathol Lab Med 138:1520–1530. https://doi.org/10.5858/arpa.2013-0691-RACrossRefPubMed

Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C et al (2015) Arizona study of aging and neurodegenerative disorders and brain and body donation program. Neuropathology 35:354–389. https://doi.org/10.1111/neup.12189CrossRefPubMedPubMedCentral

Beffert U, Morfini G, Bock HH, Reyna H, Brady ST, Herz J (2002) Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem 277:49958–49964. https://doi.org/10.1074/jbc.M209205200CrossRefPubMed

10.

Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD, Li WP, Adelmann G, Frotscher M, Hammer RE et al (2005) Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47:567–579. https://doi.org/10.1016/j.neuron.2005.07.007CrossRefPubMed

11.

Bekar LK, Wei HS, Nedergaard M (2012) The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand. J Cereb Blood Flow Metab 32:2135–2145. https://doi.org/10.1038/jcbfm.2012.115CrossRefPubMedPubMedCentral

12.

Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V et al (2022) New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet 54:412–436. https://doi.org/10.1038/s41588-022-01024-zCrossRefPubMedPubMedCentral

13.

Ben Zablah Y, Zhang H, Gugustea R, Jia Z (2021) LIM-kinases in synaptic plasticity, memory, and brain diseases. Cells. https://doi.org/10.3390/cells10082079CrossRefPubMedPubMedCentral

14.

Benjamini Y, Krieger AM, Yekutieli D (2006) Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93:491–507CrossRef

15.

Berron D, van Westen D, Ossenkoppele R, Strandberg O, Hansson O (2020) Medial temporal lobe connectivity and its associations with cognition in early Alzheimer’s disease. Brain 143:1233–1248. https://doi.org/10.1093/brain/awaa068CrossRefPubMedPubMedCentral

16.

Birdsill AC, Walker DG, Lue L, Sue LI, Beach TG (2011) Postmortem interval effect on RNA and gene expression in human brain tissue. Cell Tissue Bank 12:311–318. https://doi.org/10.1007/s10561-010-9210-8CrossRefPubMed

17.

Bock HH, Jossin Y, Liu P, Forster E, May P, Goffinet AM, Herz J (2003) Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem 278:38772–38779. https://doi.org/10.1074/jbc.M306416200CrossRefPubMed

18.

Bock HH, Jossin Y, May P, Bergner O, Herz J (2004) Apolipoprotein E receptors are required for Reelin-induced proteasomal degradation of the neuronal adaptor protein disabled-1. J Biol Chem 279:33471–33479. https://doi.org/10.1074/jbc.M401770200CrossRefPubMed

19.

Bogoslovsky T, Bernstock JD, Bull G, Gouty S, Cox BM, Hallenbeck JM, Maric D (2018) Development of a systems-based in situ multiplex biomarker screening approach for the assessment of immunopathology and neural tissue plasticity in male rats after traumatic brain injury. J Neurosci Res 96:487–500. https://doi.org/10.1002/jnr.24054CrossRefPubMed

20.

Boluda S, Toledo JB, Irwin DJ, Raible KM, Byrne MD, Lee EB, Lee VM, Trojanowski JQ (2014) A comparison of Abeta amyloid pathology staging systems and correlation with clinical diagnosis. Acta Neuropathol 128:543–550. https://doi.org/10.1007/s00401-014-1308-9CrossRefPubMedPubMedCentral

21.

Borrell V, Pujadas L, Simo S, Dura D, Sole M, Cooper JA, Del Rio JA, Soriano E (2007) Reelin and mDab1 regulate the development of hippocampal connections. Mol Cell Neurosci 36:158–173. https://doi.org/10.1016/j.mcn.2007.06.006CrossRefPubMed

22.

Bosch C, Muhaisen A, Pujadas L, Soriano E, Martinez A (2016) Reelin exerts structural, biochemical and transcriptional regulation over presynaptic and postsynaptic elements in the adult hippocampus. Front Cell Neurosci 10:138. https://doi.org/10.3389/fncel.2016.00138CrossRefPubMedPubMedCentral

23.

Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haerter PJ, Ignatius MJ et al (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Investig 83:1015–1031. https://doi.org/10.1172/JCI113943CrossRefPubMedPubMedCentral

24.

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259. https://doi.org/10.1007/BF00308809CrossRefPubMed

25.

Braak H, Braak E (1985) On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer’s disease. Acta Neuropathol 68:325–332. https://doi.org/10.1007/BF00690836CrossRefPubMed

26.

Braak H, Del Tredici K (2011) Alzheimer’s pathogenesis: Is there neuron-to-neuron propagation? Acta Neuropathol 121:589–595. https://doi.org/10.1007/s00401-011-0825-zCrossRefPubMed

27.

Braak H, Del Tredici K (2020) From the entorhinal region via the prosubiculum to the dentate fascia: Alzheimer disease-related neurofibrillary changes in the temporal allocortex. J Neuropathol Exp Neurol 79:163–175. https://doi.org/10.1093/jnen/nlz123CrossRefPubMedPubMedCentral

28.

Braak H, Del Tredici K (2015) Neuroanatomy and pathology of sporadic Alzheimer’s disease. Adv Anat Embryol Cell Biol 215:1–162CrossRefPubMed

29.

Braak H, Del Tredici K (2018) Spreading of tau pathology in sporadic Alzheimer’s disease along cortico-cortical top-down connections. Cereb Cortex 28:3372–3384. https://doi.org/10.1093/cercor/bhy152CrossRefPubMedPubMedCentral

30.

Braak H, Del Tredici K (2019) Top-down projections direct the gradual progression of Alzheimer-related tau pathology throughout the neocortex. Adv Exp Med Biol 1184:291–303. https://doi.org/10.1007/978-981-32-9358-8_22CrossRefPubMed

31.

Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969. https://doi.org/10.1097/NEN.0b013e318232a379CrossRefPubMed

32.

Bracher-Smith M, Leonenko G, Baker E, Crawford K, Graham AC, Salih DA, Howell BW, Hardy J, Escott-Price V (2022) Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer’s disease pathogenesis. Neurobiol Aging 119:67–76. https://doi.org/10.1016/j.neurobiolaging.2022.07.009CrossRefPubMedPubMedCentral

33.

Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer’s disease. J Neurochem 72:751–756. https://doi.org/10.1046/j.1471-4159.1999.0720751.xCrossRefPubMed

34.

Carter DB (2005) The interaction of amyloid-beta with ApoE. Subcell Biochem 38:255–272. https://doi.org/10.1007/0-387-23226-5_13CrossRefPubMed

35.

Chai X, Forster E, Zhao S, Bock HH, Frotscher M (2009) Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3. J Neurosci 29:288–299. https://doi.org/10.1523/JNEUROSCI.2934-08.2009CrossRefPubMedPubMedCentral

36.

Chai X, Wu S, Murray TK, Kinley R, Cella CV, Sims H, Buckner N, Hanmer J, Davies P, O’Neill MJ et al (2011) Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression. J Biol Chem 286:34457–34467. https://doi.org/10.1074/jbc.M111.229633CrossRefPubMedPubMedCentral

37.

Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L (2007) Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer’s disease. J Neurosci 27:2727–2733. https://doi.org/10.1523/JNEUROSCI.3758-06.2007CrossRefPubMedPubMedCentral

38.

Clayton NS, Fox M, Vicente-Garcia JJ, Schroeder CM, Littlewood TD, Wilde JI, Krishnan K, Brown MJB, Crafter C, Mott HR et al (2022) Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK. J Biol Chem 298:101916. https://doi.org/10.1016/j.jbc.2022.101916CrossRefPubMedPubMedCentral

39.

Colin M, Dujardin S, Schraen-Maschke S, Meno-Tetang G, Duyckaerts C, Courade JP, Buee L (2020) From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy. Acta Neuropathol 139:3–25. https://doi.org/10.1007/s00401-019-02087-9CrossRefPubMed

40.

Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923. https://doi.org/10.1126/science.8346443CrossRefPubMed

41.

Cuchillo-Ibanez I, Balmaceda V, Botella-Lopez A, Rabano A, Avila J, Saez-Valero J (2013) Beta-amyloid impairs Reelin signaling. PLoS ONE 8:e72297. https://doi.org/10.1371/journal.pone.0072297CrossRefPubMedPubMedCentral

42.

Cuchillo-Ibanez I, Balmaceda V, Mata-Balaguer T, Lopez-Font I, Saez-Valero J (2016) Reelin in Alzheimer’s disease, increased levels but impaired signaling: when more is less. J Alzheimers Dis 52:403–416. https://doi.org/10.3233/JAD-151193CrossRefPubMed

43.

Cuchillo-Ibanez I, Mata-Balaguer T, Balmaceda V, Arranz JJ, Nimpf J, Saez-Valero J (2016) The beta-amyloid peptide compromises Reelin signaling in Alzheimer’s disease. Sci Rep 6:31646. https://doi.org/10.1038/srep31646CrossRefPubMedPubMedCentral

44.

Curtis D, Bakaya K, Sharma L, Bandyopadhyay S (2020) Weighted burden analysis of exome-sequenced late-onset Alzheimer’s cases and controls provides further evidence for a role for PSEN1 and suggests involvement of the PI3K/Akt/GSK-3beta and WNT signalling pathways. Ann Hum Genet 84:291–302. https://doi.org/10.1111/ahg.12375CrossRefPubMed

45.

D’Arcangelo G (2005) Apoer2: a Reelin receptor to remember. Neuron 47:471–473. https://doi.org/10.1016/j.neuron.2005.08.001CrossRefPubMed

46.

D’Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T (1999) Reelin is a ligand for lipoprotein receptors. Neuron 24:471–479. https://doi.org/10.1016/s0896-6273(00)80860-0CrossRefPubMed

47.

de Lafuente V (2021) Memory consolidation during sleep might be regulated by the locus coeruleus. Neuroscience 453:266–267. https://doi.org/10.1016/j.neuroscience.2020.11.033CrossRefPubMed

48.

Delint-Ramirez I, Salcedo-Tello P, Bermudez-Rattoni F (2008) Spatial memory formation induces recruitment of NMDA receptor and PSD-95 to synaptic lipid rafts. J Neurochem 106:1658–1668. https://doi.org/10.1111/j.1471-4159.2008.05523.xCrossRefPubMed

49.

Dent EW, Merriam EB, Hu X (2011) The dynamic cytoskeleton: backbone of dendritic spine plasticity. Curr Opin Neurobiol 21:175–181. https://doi.org/10.1016/j.conb.2010.08.013CrossRefPubMed

50.

Deutsch SI, Rosse RB, Deutsch LH (2006) Faulty regulation of tau phosphorylation by the Reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer’s disease. Eur Neuropsychopharmacol 16:547–551. https://doi.org/10.1016/j.euroneuro.2006.01.006CrossRefPubMed

51.

Duit S, Mayer H, Blake SM, Schneider WJ, Nimpf J (2010) Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors. J Biol Chem 285:4896–4908. https://doi.org/10.1074/jbc.M109.025973CrossRefPubMed

52.

Dujardin S, Hyman BT (2019) Tau prion-like propagation: state of the art and current challenges. Adv Exp Med Biol 1184:305–325. https://doi.org/10.1007/978-981-32-9358-8_23CrossRefPubMed

53.

Dumanis SB, Cha HJ, Song JM, Trotter JH, Spitzer M, Lee JY, Weeber EJ, Turner RS, Pak DT, Rebeck GW et al (2011) ApoE receptor 2 regulates synapse and dendritic spine formation. PLoS ONE 6:e17203. https://doi.org/10.1371/journal.pone.0017203CrossRefPubMedPubMedCentral

54.

Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, Zheng H, Fisseha N, Kalluri HV, Rendenbach-Mueller B et al (2023) Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study. Brain 146:2275–2284. https://doi.org/10.1093/brain/awad024CrossRefPubMedPubMedCentral

55.

Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer’s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13:164. https://doi.org/10.3389/fnins.2019.00164CrossRefPubMedPubMedCentral

56.

Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845–12852. https://doi.org/10.1074/jbc.M808759200CrossRefPubMedPubMedCentral

57.

Frotscher M, Zhao S, Wang S, Chai X (2017) Reelin signaling inactivates cofilin to stabilize the cytoskeleton of migrating cortical neurons. Front Cell Neurosci 11:148. https://doi.org/10.3389/fncel.2017.00148CrossRefPubMedPubMedCentral

58.

Fu H, Possenti A, Freer R, Nakano Y, Hernandez Villegas NC, Tang M, Cauhy PVM, Lassus BA, Chen S, Fowler SL et al (2019) A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology. Nat Neurosci 22:47–56. https://doi.org/10.1038/s41593-018-0298-7CrossRefPubMed

59.

Fuentealba RA, Barria MI, Lee J, Cam J, Araya C, Escudero CA, Inestrosa NC, Bronfman FC, Bu G, Marzolo MP (2007) ApoER2 expression increases Abeta production while decreasing amyloid precursor protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of gamma-secretase activity. Mol Neurodegener 2:14. https://doi.org/10.1186/1750-1326-2-14CrossRefPubMedPubMedCentral

60.

Fukuda M, Kanou F, Shimada N, Sawabe M, Saito Y, Murayama S, Hashimoto M, Maruyama N, Ishigami A (2009) Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer’s disease. Biomed Res 30:227–233. https://doi.org/10.2220/biomedres.30.227CrossRefPubMed

61.

Furman JL, Vaquer-Alicea J, White CL 3rd, Cairns NJ, Nelson PT, Diamond MI (2017) Widespread tau seeding activity at early Braak stages. Acta Neuropathol 133:91–100. https://doi.org/10.1007/s00401-016-1644-zCrossRefPubMed

62.

Gallo CM, Labadorf AT, Ho A, Beffert U (2022) Single molecule, long-read Apoer2 sequencing identifies conserved and species-specific splicing patterns. Genomics 114:110318. https://doi.org/10.1016/j.ygeno.2022.110318CrossRefPubMed

63.

Greig NH, Sweeney DJ, Rapoport SI (1988) Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat. Cancer Chemother Pharmacol 21:1–8. https://doi.org/10.1007/BF00262729CrossRefPubMed

64.

Grzanna R, Molliver ME (1980) The locus coeruleus in the rat: an immunohistochemical delineation. Neuroscience 5:21–40. https://doi.org/10.1016/0306-4522(80)90068-8CrossRefPubMed

65.

Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S et al (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368:117–127. https://doi.org/10.1056/NEJMoa1211851CrossRefPubMed

66.

Gundisch S, Grundner-Culemann K, Wolff C, Schott C, Reischauer B, Machatti M, Groelz D, Schaab C, Tebbe A, Becker KF (2013) Delayed times to tissue fixation result in unpredictable global phosphoproteome changes. J Proteome Res 12:4424–4434. https://doi.org/10.1021/pr400451zCrossRefPubMed

67.

Hahn TT, McFarland JM, Berberich S, Sakmann B, Mehta MR (2012) Spontaneous persistent activity in entorhinal cortex modulates cortico-hippocampal interaction in vivo. Nat Neurosci 15:1531–1538. https://doi.org/10.1038/nn.3236CrossRefPubMed

68.

Hansen N (2017) The longevity of hippocampus-dependent memory is orchestrated by the locus coeruleus-noradrenergic system. Neural Plast 2017:2727602. https://doi.org/10.1155/2017/2727602CrossRefPubMedPubMedCentral

69.

Hasegawa M (2020) Experimental models of prion-like protein propagation. Neuropathology 40:460–466. https://doi.org/10.1111/neup.12656CrossRefPubMed

70.

Helmstaedter M (2013) Cellular-resolution connectomics: challenges of dense neural circuit reconstruction. Nat Methods 10:501–507. https://doi.org/10.1038/nmeth.2476CrossRefPubMed

71.

Heredia L, Helguera P, de Olmos S, Kedikian G, Sola Vigo F, LaFerla F, Staufenbiel M, de Olmos J, Busciglio J, Caceres A et al (2006) Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer’s disease. J Neurosci 26:6533–6542. https://doi.org/10.1523/JNEUROSCI.5567-05.2006CrossRefPubMedPubMedCentral

72.

Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J (1999) Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24:481–489. https://doi.org/10.1016/s0896-6273(00)80861-2CrossRefPubMed

73.

Hinrich AJ, Jodelka FM, Chang JL, Brutman D, Bruno AM, Briggs CA, James BD, Stutzmann GE, Bennett DA, Miller SA et al (2016) Therapeutic correction of ApoER2 splicing in Alzheimer’s disease mice using antisense oligonucleotides. EMBO Mol Med 8:328–345. https://doi.org/10.15252/emmm.201505846CrossRefPubMedPubMedCentral

74.

Hisatsune C, Umemori H, Mishina M, Yamamoto T (1999) Phosphorylation-dependent interaction of the N-methyl-d-aspartate receptor epsilon 2 subunit with phosphatidylinositol 3-kinase. Genes Cells 4:657–666. https://doi.org/10.1046/j.1365-2443.1999.00287.xCrossRefPubMed

75.

Hoareau C, Borrell V, Soriano E, Krebs MO, Prochiantz A, Allinquant B (2008) Amyloid precursor protein cytoplasmic domain antagonizes reelin neurite outgrowth inhibition of hippocampal neurons. Neurobiol Aging 29:542–553. https://doi.org/10.1016/j.neurobiolaging.2006.11.012CrossRefPubMed

76.

Hoe HS, Minami SS, Makarova A, Lee J, Hyman BT, Matsuoka Y, Rebeck GW (2008) Fyn modulation of Dab1 effects on amyloid precursor protein and ApoE receptor 2 processing. J Biol Chem 283:6288–6299. https://doi.org/10.1074/jbc.M704140200CrossRefPubMed

77.

Hoe HS, Pocivavsek A, Chakraborty G, Fu Z, Vicini S, Ehlers MD, Rebeck GW (2006) Apolipoprotein E receptor 2 interactions with the N-methyl-d-aspartate receptor. J Biol Chem 281:3425–3431. https://doi.org/10.1074/jbc.M509380200CrossRefPubMed

78.

Hoe HS, Tran TS, Matsuoka Y, Howell BW, Rebeck GW (2006) DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J Biol Chem 281:35176–35185. https://doi.org/10.1074/jbc.M602162200CrossRefPubMed

79.

Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W (2009) The unfolded protein response is activated in pretangle neurons in Alzheimer’s disease hippocampus. Am J Pathol 174:1241–1251. https://doi.org/10.2353/ajpath.2009.080814CrossRefPubMedPubMedCentral

80.

Huang Y, Shah V, Liu T, Keshvara L (2005) Signaling through Disabled 1 requires phosphoinositide binding. Biochem Biophys Res Commun 331:1460–1468. https://doi.org/10.1016/j.bbrc.2005.04.064CrossRefPubMed

81.

Huang ZJ, Cao F, Wu Y, Peng JH, Zhong JJ, Jiang Y, Yin C, Guo ZD, Sun XC, Jiang L et al (2020) Apolipoprotein E promotes white matter remodeling via the Dab1-dependent pathway after traumatic brain injury. CNS Neurosci Ther 26:698–710. https://doi.org/10.1111/cns.13298CrossRefPubMedPubMedCentral

82.

Hyman B (2022) All the tau we cannot see. Annu Rev Med. https://doi.org/10.1146/annurev-med-042921-023749CrossRefPubMed

83.

Hyman BT, Gomez-Isla T (1994) Alzheimer’s disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 15:353–354. https://doi.org/10.1016/0197-4580(94)90031-0. (discussion 379–380)CrossRefPubMed

84.

Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168–1170. https://doi.org/10.1126/science.6474172CrossRefPubMed

85.

Ignatius MJ, Gebicke-Harter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 83:1125–1129. https://doi.org/10.1073/pnas.83.4.1125CrossRefPubMedPubMedCentral

86.

Imbimbo BP, Balducci C, Ippati S, Watling M (2023) Initial failures of anti-tau antibodies in Alzheimer’s disease are reminiscent of the amyloid-beta story. Neural Regen Res 18:117–118. https://doi.org/10.4103/1673-5374.340409CrossRefPubMed

87.

Insausti R, Amaral DG (2004) CHAPTER 23—hippocampal formation. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Academic Press, London, pp 871–914CrossRef

88.

Ishizuka N, Weber J, Amaral DG (1990) Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J Comp Neurol 295:580–623. https://doi.org/10.1002/cne.902950407CrossRefPubMed

89.

Jadhav S, Avila J, Scholl M, Kovacs GG, Kovari E, Skrabana R, Evans LD, Kontsekova E, Malawska B, de Silva R et al (2019) A walk through tau therapeutic strategies. Acta Neuropathol Commun 7:22. https://doi.org/10.1186/s40478-019-0664-zCrossRefPubMedPubMedCentral

90.

Jones BE, Yang TZ (1985) The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J Comp Neurol 242:56–92. https://doi.org/10.1002/cne.902420105CrossRefPubMed

91.

Kandalepas PC, Sadleir KR, Eimer WA, Zhao J, Nicholson DA, Vassar R (2013) The Alzheimer’s beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol 126:329–352. https://doi.org/10.1007/s00401-013-1152-3CrossRefPubMedPubMedCentral

92.

Kaufman SK, Del Tredici K, Thomas TL, Braak H, Diamond MI (2018) Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART. Acta Neuropathol 136:57–67. https://doi.org/10.1007/s00401-018-1855-6CrossRefPubMedPubMedCentral

93.

Kim DH, Iijima H, Goto K, Sakai J, Ishii H, Kim HJ, Suzuki H, Kondo H, Saeki S, Yamamoto T (1996) Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem 271:8373–8380. https://doi.org/10.1074/jbc.271.14.8373CrossRefPubMed

94.

Kobro-Flatmoen A, Battistin C, Nair RR, Bjorkli C, Skender B, Kentros C, Gouras G, Witter MP (2023) Lowering levels of reelin in entorhinal cortex layer II-neurons results in lowered levels of intracellular amyloid-beta. Brain Commun 5:fcad115. https://doi.org/10.1093/braincomms/fcad115CrossRefPubMedPubMedCentral

95.

Kobro-Flatmoen A, Nagelhus A, Witter MP (2016) Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer’s disease. Neurobiol Dis 93:172–183. https://doi.org/10.1016/j.nbd.2016.05.012CrossRefPubMed

96.

Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM, Knuesel I (2010) Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer’s disease mice. J Neurosci 30:9228–9240. https://doi.org/10.1523/JNEUROSCI.0418-10.2010CrossRefPubMedPubMedCentral

97.

Kohler C (2016) Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology. Acta Neuropathol 132:339–359. https://doi.org/10.1007/s00401-016-1562-0CrossRefPubMed

98.

Kruger MT, Zhao S, Chai X, Brunne B, Bouche E, Bock HH, Frotscher M (2010) Role for Reelin-induced cofilin phosphorylation in the assembly of sympathetic preganglionic neurons in the murine intermediolateral column. Eur J Neurosci 32:1611–1617. https://doi.org/10.1111/j.1460-9568.2010.07433.xCrossRefPubMed

99.

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A et al (2019) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51:414–430. https://doi.org/10.1038/s41588-019-0358-2CrossRefPubMedPubMedCentral

100.

Kupferman JV, Basu J, Russo MJ, Guevarra J, Cheung SK, Siegelbaum SA (2014) Reelin signaling specifies the molecular identity of the pyramidal neuron distal dendritic compartment. Cell 158:1335–1347. https://doi.org/10.1016/j.cell.2014.07.035CrossRefPubMedPubMedCentral

101.

Leeb C, Eresheim C, Nimpf J (2014) Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway. J Biol Chem 289:4161–4172. https://doi.org/10.1074/jbc.M113.529271CrossRefPubMed

102.

Leemhuis J, Bouche E, Frotscher M, Henle F, Hein L, Herz J, Meyer DK, Pichler M, Roth G, Schwan C et al (2010) Reelin signals through apolipoprotein E receptor 2 and Cdc42 to increase growth cone motility and filopodia formation. J Neurosci 30:14759–14772. https://doi.org/10.1523/JNEUROSCI.4036-10.2010CrossRefPubMedPubMedCentral

103.

Lewis J, Dickson DW (2016) Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:27–48. https://doi.org/10.1007/s00401-015-1507-zCrossRefPubMed

104.

Li H, Liu H, Lutz MW, Luo S, Alzheimer’s Disease Neuroimaging I (2023) Novel genetic variants in TP37, PIK3R1, CALM1, and PLCG2 of the neurotrophin signaling pathway are associated with the progression from mild cognitive impairment to Alzheimer’s disease. J Alzheimers Dis 91:977–987. https://doi.org/10.3233/JAD-220680CrossRefPubMedPubMedCentral

105.

Li XG, Somogyi P, Ylinen A, Buzsaki G (1994) The hippocampal CA3 network: an in vivo intracellular labeling study. J Comp Neurol 339:181–208. https://doi.org/10.1002/cne.903390204CrossRefPubMed

106.

Lichtman JW, Pfister H, Shavit N (2014) The big data challenges of connectomics. Nat Neurosci 17:1448–1454. https://doi.org/10.1038/nn.3837CrossRefPubMedPubMedCentral

107.

Lim JS, Kim HJ, Park I, Woo S, Kim JH, Park JW (2022) Force mapping reveals the spatial distribution of individual proteins in a neuron. Nano Lett 22:3865–3871. https://doi.org/10.1021/acs.nanolett.1c04395CrossRefPubMed

108.

Liu Q, Raina AK, Smith MA, Sayre LM, Perry G (2003) Hydroxynonenal, toxic carbonyls, and Alzheimer disease. Mol Aspects Med 24:305–313. https://doi.org/10.1016/s0098-2997(03)00025-6CrossRefPubMed

109.

Lopera F, Marino C, Chandrahas AS, O’Hare M, Villalba-Moreno ND, Aguillon D, Baena A, Sanchez JS, Vila-Castelar C, Ramirez Gomez L et al (2023) Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man. Nat Med 29:1243–1252. https://doi.org/10.1038/s41591-023-02318-3CrossRefPubMedPubMedCentral

110.

Ma F, Akolkar H, Xu J, Liu Y, Popova D, Xie J, Youssef MM, Benosman R, Hart RP, Herrup K (2023) The amyloid precursor protein modulates the position and length of the axon initial segment. J Neurosci 43:1830–1844. https://doi.org/10.1523/JNEUROSCI.0172-22.2023CrossRefPubMedPubMedCentral

111.

Manelli AM, Stine WB, Van Eldik LJ, LaDu MJ (2004) ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. J Mol Neurosci 23:235–246. https://doi.org/10.1385/JMN:23:3:235CrossRefPubMed

112.

Maric D, Jahanipour J, Li XR, Singh A, Mobiny A, Van Nguyen H, Sedlock A, Grama K, Roysam B (2021) Whole-brain tissue mapping toolkit using large-scale highly multiplexed immunofluorescence imaging and deep neural networks. Nat Commun 12:1550. https://doi.org/10.1038/s41467-021-21735-xCrossRefPubMedPubMedCentral

113.

Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23:134–147. https://doi.org/10.1016/s0891-5849(96)00629-6CrossRefPubMed

114.

Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD (2005) Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 58:730–735. https://doi.org/10.1002/ana.20629CrossRefPubMed

115.

Monti JM (2010) The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness. Sleep Med Rev 14:307–317. https://doi.org/10.1016/j.smrv.2009.11.004CrossRefPubMed

116.

Montine KS, Olson SJ, Amarnath V, Whetsell WO Jr, Graham DG, Montine TJ (1997) Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer’s disease is associated with inheritance of APOE4. Am J Pathol 150:437–443PubMedPubMedCentral

117.

Morrison JH, Foote SL, O’Connor D, Bloom FE (1982) Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: dopamine-beta-hydroxylase immunohistochemistry. Brain Res Bull 9:309–319. https://doi.org/10.1016/0361-9230(82)90144-7CrossRefPubMed

118.

Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Alavi Naini SM, Mandelkow EM, Mandelkow E, Buee L, Goedert M et al (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5:99. https://doi.org/10.1186/s40478-017-0488-7CrossRefPubMedPubMedCentral

119.

Mullard A (2021) Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating. Nat Rev Drug Discov 20:3–5. https://doi.org/10.1038/d41573-020-00217-7CrossRefPubMed

120.

Murray HC, Johnson K, Sedlock A, Highet B, Dieriks BV, Anekal PV, Faull RLM, Curtis MA, Koretsky A, Maric D (2022) Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patients. Commun Biol 5:88. https://doi.org/10.1038/s42003-022-03032-5CrossRefPubMedPubMedCentral

121.

Nelson CD, Kim MJ, Hsin H, Chen Y, Sheng M (2013) Phosphorylation of threonine-19 of PSD-95 by GSK-3beta is required for PSD-95 mobilization and long-term depression. J Neurosci 33:12122–12135. https://doi.org/10.1523/JNEUROSCI.0131-13.2013CrossRefPubMedPubMedCentral

122.

Nichols JB, Malek-Ahmadi M, Tariot PN, Serrano GE, Sue LI, Beach TG (2021) Vascular lesions, APOE epsilon4, and Tau pathology in Alzheimer disease. J Neuropathol Exp Neurol 80:240–246. https://doi.org/10.1093/jnen/nlaa160CrossRefPubMedPubMedCentral

123.

Nishikawa T, Takahashi T, Nakamori M, Hosomi N, Maruyama H, Miyazaki Y, Izumi Y, Matsumoto M (2016) The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments. Neuropathol Appl Neurobiol 42:639–653. https://doi.org/10.1111/nan.12288CrossRefPubMed

124.

Niu S, Renfro A, Quattrocchi CC, Sheldon M, D’Arcangelo G (2004) Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 41:71–84. https://doi.org/10.1016/s0896-6273(03)00819-5CrossRefPubMed

125.

Ohkubo N, Lee YD, Morishima A, Terashima T, Kikkawa S, Tohyama M, Sakanaka M, Tanaka J, Maeda N, Vitek MP et al (2003) Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J 17:295–297. https://doi.org/10.1096/fj.02-0434fjeCrossRefPubMed

126.

Omuro KC, Gallo CM, Scrandis L, Ho A, Beffert U (2022) Human APOER2 isoforms have differential cleavage events and synaptic properties. J Neurosci 42:4054–4068. https://doi.org/10.1523/JNEUROSCI.1800-21.2022CrossRefPubMedPubMedCentral

127.

Otero-Garcia M, Mahajani SU, Wakhloo D, Tang W, Xue YQ, Morabito S, Pan J, Oberhauser J, Madira AE, Shakouri T et al (2022) Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease. Neuron 110:2929–2948. https://doi.org/10.1016/j.neuron.2022.06.021CrossRefPubMedPubMedCentral

128.

Petit-Turcotte C, Aumont N, Beffert U, Dea D, Herz J, Poirier J (2005) The apoE receptor apoER2 is involved in the maintenance of efficient synaptic plasticity. Neurobiol Aging 26:195–206. https://doi.org/10.1016/j.neurobiolaging.2004.04.007CrossRefPubMed

129.

Pikkarainen M, Martikainen P, Alafuzoff I (2010) The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Exp Neurol 69:40–52. https://doi.org/10.1097/NEN.0b013e3181c6c13dCrossRefPubMed

130.

Qiu S, Weeber EJ (2007) Reelin signaling facilitates maturation of CA1 glutamatergic synapses. J Neurophysiol 97:2312–2321. https://doi.org/10.1152/jn.00869.2006CrossRefPubMed

131.

Ramsden CE, Keyes GS, Calzada E, Horowitz MS, Zamora D, Jahanipour J, Sedlock A, Indig FE, Moaddel R, Kapogiannis D et al (2022) Lipid peroxidation induced ApoE receptor-ligand disruption as a unifying hypothesis underlying sporadic Alzheimer’s disease in humans. J Alzheimers Dis 87:1251–1290. https://doi.org/10.3233/JAD-220071CrossRefPubMedPubMedCentral

132.

Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron 11:575–580. https://doi.org/10.1016/0896-6273(93)90070-8CrossRefPubMed

133.

Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J et al (2020) Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun 11:667. https://doi.org/10.1038/s41467-019-14279-8CrossRefPubMedPubMedCentral

134.

Riddell DR, Sun XM, Stannard AK, Soutar AK, Owen JS (2001) Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane. J Lipid Res 42:998–1002CrossRefPubMed

135.

Riedel A, Miettinen R, Stieler J, Mikkonen M, Alafuzoff I, Soininen H, Arendt T (2003) Reelin-immunoreactive Cajal–Retzius cells: the entorhinal cortex in normal aging and Alzheimer’s disease. Acta Neuropathol 106:291–302. https://doi.org/10.1007/s00401-003-0729-7CrossRefPubMed

136.

Rossi D, Gruart A, Contreras-Murillo G, Muhaisen A, Avila J, Delgado-Garcia JM, Pujadas L, Soriano E (2020) Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy. Prog Neurobiol 186:101743. https://doi.org/10.1016/j.pneurobio.2019.101743CrossRefPubMed

137.

Sadleir KR, Kandalepas PC, Buggia-Prevot V, Nicholson DA, Thinakaran G, Vassar R (2016) Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Abeta generation in Alzheimer’s disease. Acta Neuropathol 132:235–256. https://doi.org/10.1007/s00401-016-1558-9CrossRefPubMedPubMedCentral

138.

Sankaranarayanan S, Barten DM, Vana L, Devidze N, Yang L, Cadelina G, Hoque N, DeCarr L, Keenan S, Lin A et al (2015) Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models. PLoS ONE 10:e0125614. https://doi.org/10.1371/journal.pone.0125614CrossRefPubMedPubMedCentral

139.

Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. J Neurochem 68:2092–2097. https://doi.org/10.1046/j.1471-4159.1997.68052092.xCrossRefPubMed

140.

Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, Smith C, Cooper G, Mendiondo M, Danner DD, Van Eldik LJ et al (2012) University of Kentucky Sanders–Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res 9:724–733. https://doi.org/10.2174/156720512801322591CrossRefPubMedPubMedCentral

141.

Seki E, Komori T, Arai N (2022) Distribution of amyloid-beta precursor protein-immunoreactive axons differs according to the severity of cerebral ischemia in autopsy brains. Neuropathology 42:269–273. https://doi.org/10.1111/neup.12809CrossRefPubMed

142.

Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189. https://doi.org/10.1101/cshperspect.a006189CrossRefPubMedPubMedCentral

143.

Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer’s. Nature 382:120–121. https://doi.org/10.1038/382120b0CrossRefPubMed

144.

Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, Sayre LM, Perry G (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer’s disease. J Neurochem 64:2660–2666. https://doi.org/10.1046/j.1471-4159.1995.64062660.xCrossRefPubMed

145.

StataCorp (2021) Stata statistical software: release 17. StataCorp LLC, College Station

146.

Stolt PC, Chen Y, Liu P, Bock HH, Blacklow SC, Herz J (2005) Phosphoinositide binding by the disabled-1 PTB domain is necessary for membrane localization and Reelin signal transduction. J Biol Chem 280:9671–9677. https://doi.org/10.1074/jbc.M413356200CrossRefPubMed

147.

Stolt PC, Jeon H, Song HK, Herz J, Eck MJ, Blacklow SC (2003) Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes. Structure 11:569–579. https://doi.org/10.1016/s0969-2126(03)00068-6CrossRefPubMed

148.

Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977–1981. https://doi.org/10.1073/pnas.90.5.1977CrossRefPubMedPubMedCentral

149.

Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098–8102. https://doi.org/10.1073/pnas.90.17.8098CrossRefPubMedPubMedCentral

150.

Szabo MP, Mishra S, Knupp A, Young JE (2022) The role of Alzheimer’s disease risk genes in endolysosomal pathways. Neurobiol Dis 162:105576. https://doi.org/10.1016/j.nbd.2021.105576CrossRefPubMed

151.

Thal DR, Del Tredici K, Ludolph AC, Hoozemans JJ, Rozemuller AJ, Braak H, Knippschild U (2011) Stages of granulovacuolar degeneration: their relation to Alzheimer’s disease and chronic stress response. Acta Neuropathol 122:577–589. https://doi.org/10.1007/s00401-011-0871-6CrossRefPubMed

152.

The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. Neurobiol Aging 18:S1-2CrossRef

153.

Trotter J, Lee GH, Kazdoba TM, Crowell B, Domogauer J, Mahoney HM, Franco SJ, Muller U, Weeber EJ, D’Arcangelo G (2013) Dab1 is required for synaptic plasticity and associative learning. J Neurosci 33:15652–15668. https://doi.org/10.1523/JNEUROSCI.2010-13.2013CrossRefPubMedPubMedCentral

154.

Uddin MS, Hasana S, Hossain MF, Islam MS, Behl T, Perveen A, Hafeez A, Ashraf GM (2021) Molecular genetics of early- and late-onset Alzheimer’s disease. Curr Gene Ther 21:43–52. https://doi.org/10.2174/1566523220666201123112822CrossRefPubMed

155.

Urbanska M, Swiech L, Jaworski J (2012) Developmental plasticity of the dendritic compartment: focus on the cytoskeleton. Adv Exp Med Biol 970:265–284. https://doi.org/10.1007/978-3-7091-0932-8_12CrossRefPubMed

156.

Ventruti A, Kazdoba TM, Niu S, D’Arcangelo G (2011) Reelin deficiency causes specific defects in the molecular composition of the synapses in the adult brain. Neuroscience 189:32–42. https://doi.org/10.1016/j.neuroscience.2011.05.050CrossRefPubMed

157.

Waldvogel HJ, Curtis MA, Baer K, Rees MI, Faull RL (2006) Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc 1:2719–2732. https://doi.org/10.1038/nprot.2006.354CrossRefPubMed

158.

Walker DG, Whetzel AM, Serrano G, Sue LI, Lue LF, Beach TG (2016) Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program. Cell Tissue Bank 17:361–375. https://doi.org/10.1007/s10561-016-9555-8CrossRefPubMedPubMedCentral

159.

Wang G, Lei J, Wang Y, Yu J, He Y, Zhao W, Hu Z, Xu Z, Jin Y, Gu Y et al (2022) The ZSWIM8 ubiquitin ligase regulates neurodevelopment by guarding the protein quality of intrinsically disordered Dab1. Cereb Cortex. https://doi.org/10.1093/cercor/bhac313CrossRefPubMedPubMedCentral

160.

Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, Arrighi HM (2012) Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer’s disease: a systematic review and meta-analysis. Neuroepidemiology 38:1–17. https://doi.org/10.1159/000334607CrossRefPubMed

161.

Watamura N, Sato K, Saido TC (2022) Mouse models of Alzheimer’s disease for preclinical research. Neurochem Int 158:105361. https://doi.org/10.1016/j.neuint.2022.105361CrossRefPubMed

162.

Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J (2002) Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944–39952. https://doi.org/10.1074/jbc.M205147200CrossRefPubMed

163.

Wu X, Deng C, Su Y, Zhang C, Chen M, Tian K, Wu H, Xu S (2022) The effect of prolonged formalin fixation on the expression of proteins in human brain tissues. Acta Histochem 124:151879. https://doi.org/10.1016/j.acthis.2022.151879CrossRefPubMed

164.

Yamaguchi H, Nakazato Y, Shoji M, Ihara Y, Hirai S (1990) Ultrastructure of the neuropil threads in the Alzheimer brain: their dendritic origin and accumulation in the senile plaques. Acta Neuropathol 80:368–374. https://doi.org/10.1007/BF00307689CrossRefPubMed

165.

Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M (2016) TREM2 binds to apolipoproteins, including APOE and CLU/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91:328–340. https://doi.org/10.1016/j.neuron.2016.06.015CrossRefPubMed

166.

Yun M, Keshvara L, Park CG, Zhang YM, Dickerson JB, Zheng J, Rock CO, Curran T, Park HW (2003) Crystal structures of the Dab homology domains of mouse disabled 1 and 2. J Biol Chem 278:36572–36581. https://doi.org/10.1074/jbc.M304384200CrossRefPubMed

167.

Zhu X, Castellani RJ, Moreira PI, Aliev G, Shenk JC, Siedlak SL, Harris PLR, Fujioka H, Sayre LM, Szweda PA et al (2012) Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radic Biol Med 52:699–704. https://doi.org/10.1016/j.freeradbiomed.2011.11.004CrossRefPubMed

Title: ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease
Authors: Christopher E. Ramsden
Daisy Zamora
Mark S. Horowitz
Jahandar Jahanipour
Elizabeth Calzada
Xiufeng Li
Gregory S. Keyes
Helen C. Murray
Maurice A. Curtis
Richard M. Faull
Andrea Sedlock
Dragan Maric
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Alzheimer's Disease
Alzheimer's Disease
Mild Neurocognitive Disorder
Pathology
Published in: Acta Neuropathologica Communications / Issue 1/2023
Electronic ISSN: 2051-5960
DOI: https://doi.org/10.1186/s40478-023-01693-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2023

Lack of a protective effect of the Tmem106b “protective SNP” in the Grn knockout mouse model for frontotemporal lobar degeneration

Patterns of synaptic loss in human amyotrophic lateral sclerosis spinal cord: a clinicopathological study

Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus

Spatio-temporal dynamics of microglia phenotype in human and murine cSVD: impact of acute and chronic hypertensive states

Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration

A neuropathologic feature of brain aging: multi-lumen vascular profiles